Mammalian protein found in Homo sapiens
SLC22A12 |
---|
|
Identifiers |
---|
Aliases | SLC22A12, solute carrier family 22 (organic anion/urate transporter), member 12, OAT4L, RST, URAT1, solute carrier family 22 member 12 |
---|
External IDs | OMIM: 607096 MGI: 1195269 HomoloGene: 56442 GeneCards: SLC22A12 |
---|
|
Gene location (Mouse) |
---|
 | Chr. | Chromosome 19 (mouse) |
---|
| Band | 19|19 A | Start | 6,585,875 bp |
---|
End | 6,593,062 bp |
---|
|
|
|
|
Wikidata |
|
Solute carrier family 22 (organic anion/cation transporter), member 12, also known as SLC22A12 and URAT1, is a protein which in humans is encoded by the SLC22A12 gene.
Function
The protein encoded by this gene is a urate transporter and urate-anion exchanger which regulates the level of urate in the blood. This protein is an integral membrane protein primarily found in kidney. Two transcript variants encoding different isoforms have been found for this gene.
Clinical significance
Numerous single nucleotide polymorphisms of this gene are significantly associated with altered (increased or decreased) reabsorption of uric acid by the kidneys. Respectively, these altered rates of reabsorption contribute to hyperuricemia and hypouricemia.
Interactions
SLC22A12 has been shown to interact with PDZK1.
Inhibition
Lesinurad and dotinurad are urate transporter inhibitors that have been approved to treat gout. Lesinurad enhances urate excretion by inhibition the tubular re-absorption. Probenecid also facilitates uric acid secretion.
See also
|
---|
By group |
---|
SLC1–10 |
---|
(1): | |
---|
(2): | |
---|
(3): | |
---|
(4): | |
---|
(5): | |
---|
(6): | |
---|
(7): | |
---|
(8): | |
---|
(9): | |
---|
(10): | |
---|
|
| SLC11–20 |
---|
(11): |
- proton coupled metal ion transporter
|
---|
(12): | |
---|
(13): |
- human Na+-sulfate/carboxylate cotransporter
|
---|
(14): | |
---|
(15): |
- proton oligopeptide cotransporter
|
---|
(16): |
- monocarboxylate transporter
|
---|
(17): | |
---|
(18): | |
---|
(19): | |
---|
(20): | |
---|
|
| SLC21–30 |
---|
(21): | |
---|
(22): | |
---|
(23): |
- Na+-dependent ascorbic acid transporter
|
---|
(24): | |
---|
(25): | |
---|
(26): |
- multifunctional anion exchanger
|
---|
(27): | |
---|
(28): |
- Na+-coupled nucleoside transport (SLC28A1
|
---|
(29): |
- facilitative nucleoside transporter
|
---|
(30): | |
---|
|
| SLC31–40 |
---|
(31): | |
---|
(32): | |
---|
(33): | |
---|
(34): |
- type II Na+-phosphate cotransporter
|
---|
(35): |
- nucleoside-sugar transporter
-
-
-
-
- SLC35E1
- SLC35E2
- SLC35E3
- SLC35E4
|
---|
(36): |
- proton-coupled amino-acid transporter
|
---|
(37): |
- sugar-phosphate/phosphate exchanger
|
---|
(38): |
- System A & N, sodium-coupled neutral amino-acid transporter
|
---|
(39): | |
---|
(40): |
- basolateral iron transporter
|
---|
|
| SLC41–48 |
---|
(41): | |
---|
(42): | |
---|
(43): |
- Na+-independent, system-L like amino-acid transporter
|
---|
(44): | |
---|
(45): |
- Putative sugar transporter
|
---|
(46): | |
---|
(47): | |
---|
(48): | |
---|
|
| |
|
|
|
see also solute carrier disorders |